Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Urine-based diagnostics
Der Urologe, 07/02/09
Hautmann S et al. - The current mode of detecting bladder cancer involves cystoscopy, which is an invasive and relatively expensive procedure. Voided urine cytology, the standard noninvasive marker, is highly tumor specific and has good sensitivity for detecting high-grade tumors. However, its sensitivity for detecting low-grade tumors is low.
Related Articles
Molecular Diagnostics and Predictors in Thyroid Cancer
Thyroid, 11/19/09
Relevance Score: 93%
Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease
The International Journal of Tuberculosis and Lung Disease, 10/30/09
Relevance Score: 91%
The role of EBUS-TBNA for the diagnosis of sarcoidosis – comparisons with other bronchoscopic diagnostic modalities
Respiratory Medicine, 11/18/09
Relevance Score: 89%
Magnetic resonance imaging and magnetic resonance arthrography of the shoulder: dependence on the level of training of the performing radiologist for diagnostic accuracy
Skeletal Radiology, 10/21/09
Relevance Score: 89%
Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended
BJU International, 10/13/09
Relevance Score: 89%
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
A MicroRNA expression profile defining the invasive bladder tumor phenotype
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Combination of vesicoureteric reflux and vesicoureteric junction obstruction
Scandinavian Journal of Urology and Nephrology, 12/18/09
Behavioral Intervention versus Pharmacotherapy or Their Combinations in the Management of Overactive Bladder Dysfunction
Advances in Urology, 12/18/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
Cancer Research, 12/18/09
Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/18/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles
The Prostate, 12/18/09
Influence of Cytokine Gene Polymorphisms on Prostate-Specific Antigen Recurrence in Prostate Cancer after Radical Prostatectomy
Urologia Internationalis, 12/18/09
Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence
Medical Oncology, 12/18/09
Article Search
Sponsor


See Latest Articles


